Skip to main content
Erschienen in: European Journal of Pediatrics 7-8/2003

01.07.2003 | Original Paper

A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin

verfasst von: Katja C. Wolthers, René F. Kornelisse, Gert J. J. M. Platenkamp, M. Inge Schuurman-van der Lem, Cindy van der Schee, Nico G. Hartwig, Cees M. Verduin

Erschienen in: European Journal of Pediatrics | Ausgabe 7-8/2003

Einloggen, um Zugang zu erhalten

Abstract

The role of Mycoplasma hominis as a causative agent for neonatal sepsis and meningitis is still unclear. Meningitis secondary to M. hominis is well-described in the literature; however, M. hominis can also be isolated from cerebrospinal fluid (CSF) obtained from infants without signs of meningitis. We present a case of a full-term infant with meningo-encephalitis with seizures, epileptic activity on the EEG, inflammation of brain tissue on a CT scan, and cloudy CSF containing elevated cell counts, decreased glucose levels and elevated protein levels. M. hominis was identified from the CSF by culture and by polymerase chain reaction (PCR) as the only possible causative agent. Furthermore, while empiric antibiotic and antiviral treatment for neonatal sepsis had failed, the meningo-encephalitis promptly responded upon antibiotic treatment with ciprofloxacin (20 mg/kg per day i.v.), to which M. hominis is susceptible. Conclusion: a meningo-encephalitis developed due to infection with M. hominis in a full-term infant, from which he recovered rapidly after start of treatment with ciprofloxacin.
Literatur
1.
Zurück zum Zitat Alonso-Vega C, Wauters N, Vermeylen D, Muller MF, Serruys E (1997) A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn. J Clin Microbiol 35: 286–287PubMedPubMedCentral Alonso-Vega C, Wauters N, Vermeylen D, Muller MF, Serruys E (1997) A fatal case of Mycoplasma hominis meningoencephalitis in a full-term newborn. J Clin Microbiol 35: 286–287PubMedPubMedCentral
2.
Zurück zum Zitat Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402CrossRefPubMedPubMedCentral Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Burkhardt JE, Walterspiel JN, Schaad UB (1997) Quinolone arthropathy in animals versus children. Clin Infect Dis 25: 1196–1204CrossRefPubMed Burkhardt JE, Walterspiel JN, Schaad UB (1997) Quinolone arthropathy in animals versus children. Clin Infect Dis 25: 1196–1204CrossRefPubMed
4.
Zurück zum Zitat Cassell GH, Waites KB, Crouse DT (2001) Mycoplasmal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. Saunders, Philadelphia, pp 733–767 Cassell GH, Waites KB, Crouse DT (2001) Mycoplasmal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant. Saunders, Philadelphia, pp 733–767
5.
Zurück zum Zitat Dosa E, Nagy E, Falk W, Szoke I, Ballies U (1999) Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum. J Antimicrob Chemother 43: 575–578CrossRefPubMed Dosa E, Nagy E, Falk W, Szoke I, Ballies U (1999) Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum. J Antimicrob Chemother 43: 575–578CrossRefPubMed
6.
Zurück zum Zitat Gewitz M, Dinwiddie R, Rees L, Volikas O, Yuille T, O'Connell B, Marshall WC (1979) Mycoplasma hominis. A cause of neonatal meningitis. Arch Dis Child 54: 231–233CrossRefPubMedPubMedCentral Gewitz M, Dinwiddie R, Rees L, Volikas O, Yuille T, O'Connell B, Marshall WC (1979) Mycoplasma hominis. A cause of neonatal meningitis. Arch Dis Child 54: 231–233CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Kenny GE, Cartwright FD (2001) Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 45: 2604–2608CrossRefPubMedPubMedCentral Kenny GE, Cartwright FD (2001) Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 45: 2604–2608CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kirk N, Kovar I (1987) Mycoplasma hominis meningitis in a preterm infant. J Infect 15: 109–110CrossRefPubMed Kirk N, Kovar I (1987) Mycoplasma hominis meningitis in a preterm infant. J Infect 15: 109–110CrossRefPubMed
9.
Zurück zum Zitat Likitnukul S, Kusmiesz H, Nelson JD, McCracken GH Jr (1986) Role of genital mycoplasmas in young infants with suspected sepsis. J Pediatr 109: 971–974CrossRefPubMed Likitnukul S, Kusmiesz H, Nelson JD, McCracken GH Jr (1986) Role of genital mycoplasmas in young infants with suspected sepsis. J Pediatr 109: 971–974CrossRefPubMed
10.
Zurück zum Zitat McCormack WM (1993) Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin Infect Dis 17[Suppl 1]: S200–S201CrossRefPubMed McCormack WM (1993) Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin Infect Dis 17[Suppl 1]: S200–S201CrossRefPubMed
11.
Zurück zum Zitat McDonald JC, Moore DL (1988) Mycoplasma hominis meningitis in a premature infant. Pediatr Infect Dis J 7: 795–798CrossRefPubMed McDonald JC, Moore DL (1988) Mycoplasma hominis meningitis in a premature infant. Pediatr Infect Dis J 7: 795–798CrossRefPubMed
12.
Zurück zum Zitat McNaughton RD, Robertson JA, Ratzlaff VJ, Molberg CR (1983) Mycoplasma hominis infection of the central nervous system in a neonate. Can Med Assoc J 129: 353–354PubMedPubMedCentral McNaughton RD, Robertson JA, Ratzlaff VJ, Molberg CR (1983) Mycoplasma hominis infection of the central nervous system in a neonate. Can Med Assoc J 129: 353–354PubMedPubMedCentral
14.
Zurück zum Zitat Siber GR, Alpert S, Smith AL, Lin JS, McCormack WM (1977) Neonatal central nervous system infection due to Mycoplasma hominis. J Pediatr 90: 625–627CrossRefPubMed Siber GR, Alpert S, Smith AL, Lin JS, McCormack WM (1977) Neonatal central nervous system infection due to Mycoplasma hominis. J Pediatr 90: 625–627CrossRefPubMed
15.
Zurück zum Zitat Taylor-Robinson D (2000) Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 2027–2032 Taylor-Robinson D (2000) Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 2027–2032
16.
Zurück zum Zitat Ullmann U, Schubert S, Krausse R (1999) Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J Antimicrob Chemother 43[Suppl C]: 33–36 Ullmann U, Schubert S, Krausse R (1999) Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. J Antimicrob Chemother 43[Suppl C]: 33–36
17.
Zurück zum Zitat Valencia GB, Banzon F, Cummings M, McCormack WM, Glass L, Hammerschlag MR (1993) Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection. Pediatr Infect Dis J 12: 571–573CrossRefPubMed Valencia GB, Banzon F, Cummings M, McCormack WM, Glass L, Hammerschlag MR (1993) Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection. Pediatr Infect Dis J 12: 571–573CrossRefPubMed
18.
Zurück zum Zitat Waites KB, Canupp KC, Kenny GE (1999) In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob Agents Chemother 43: 2571–2573PubMedPubMedCentral Waites KB, Canupp KC, Kenny GE (1999) In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob Agents Chemother 43: 2571–2573PubMedPubMedCentral
19.
Zurück zum Zitat Waites KB, Duffy LB, Crouse DT, Dworsky ME, Strange MJ, Nelson KG, Cassell GH (1990) Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 9: 241–245CrossRefPubMed Waites KB, Duffy LB, Crouse DT, Dworsky ME, Strange MJ, Nelson KG, Cassell GH (1990) Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 9: 241–245CrossRefPubMed
20.
Zurück zum Zitat Wealthall SR (1975) Mycoplasma meningitis in infants with spina bifida. Dev Med Child Neurol Suppl 35: 117–122 Wealthall SR (1975) Mycoplasma meningitis in infants with spina bifida. Dev Med Child Neurol Suppl 35: 117–122
Metadaten
Titel
A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin
verfasst von
Katja C. Wolthers
René F. Kornelisse
Gert J. J. M. Platenkamp
M. Inge Schuurman-van der Lem
Cindy van der Schee
Nico G. Hartwig
Cees M. Verduin
Publikationsdatum
01.07.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 7-8/2003
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-003-1219-6

Weitere Artikel der Ausgabe 7-8/2003

European Journal of Pediatrics 7-8/2003 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.